Judge Sets Deadline For Prempro MDL Discovery
The judge presiding over a slew of cases alleging that Prempro and related hormone-replacement drugs cause breast cancer has ordered the plaintiffs to end their drawn-out discovery involving defendants Pfizer Inc....To view the full article, register now.
Already a subscriber? Click here to view full article